Cancer Nanotheranostics: What Have We Learned So Far?

Cancer Nanotheranostics: What Have We Learned So Far?
Author :
Publisher : Frontiers Media SA
Total Pages : 130
Release :
ISBN-10 : 9782889197767
ISBN-13 : 288919776X
Rating : 4/5 (76X Downloads)

Book Synopsis Cancer Nanotheranostics: What Have We Learned So Far? by : João Conde

Download or read book Cancer Nanotheranostics: What Have We Learned So Far? written by João Conde and published by Frontiers Media SA. This book was released on 2016-03-17 with total page 130 pages. Available in PDF, EPUB and Kindle. Book excerpt: After a quarter of century of rapid technological advances, research has revealed the complexity of cancer, a disease intimately related to the dynamic transformation of the genome. However, the full understanding of the molecular onset of this disease is still far from achieved and the search for mechanisms of treatment will follow closely. It is here that Nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. In fact, the National Cancer Institute predicts that over the next years, nanotechnology will result in important advances in early detection, molecular imaging, targeted and multifunctional therapeutics, prevention and control of cancer. Nanotechnology offers numerous tools to diagnose and treat cancer, such as new imaging agents, multifunctional devices capable of overcome biological barriers to deliver therapeutic agents directly to cells and tissues involved in cancer growth and metastasis, and devices capable of predicting molecular changes to prevent action against precancerous cells. Nanomaterials-based delivery systems in Theranostics (Diagnostics & Therapy) provide better penetration of therapeutic and diagnostic substances within the body at a reduced risk in comparison to conventional therapies. At the present time, there is a growing need to enhance the capability of theranostics procedures where nanomaterials-based sensors may provide for the simultaneous detection of several gene-associated conditions and nanodevices with the ability to monitor real-time drug action. These innovative multifunctional nanocarriers for cancer theranostics may allow the development of diagnostics systems such as colorimetric and immunoassays, and in therapy approaches through gene therapy, drug delivery and tumor targeting systems in cancer. Some of the thousands and thousands of published nanosystems so far will most likely revolutionize our understanding of biological mechanisms and push forward the clinical practice through their integration in future diagnostics platforms. Nevertheless, despite the significant efforts towards the use of nanomaterials in biologically relevant research, more in vivo studies are needed to assess the applicability of these materials as delivery agents. In fact, only a few went through feasible clinical trials. Nanomaterials have to serve as the norm rather than an exception in the future conventional cancer treatments. Future in vivo work will need to carefully consider the correct choice of chemical modifications to incorporate into the multifunctional nanocarriers to avoid activation off-target, side effects and toxicity. Moreover the majority of studies on nanomaterials do not consider the final application to guide the design of nanomaterial. Instead, the focus is predominantly on engineering materials with specific physical or chemical properties. It is imperative to learn how advances in nanosystem’s capabilities are being used to identify new diagnostic and therapy tools driving the development of personalized medicine in oncology; discover how integrating cancer research and nanotechnology modeling can help patient diagnosis and treatment; recognize how to translate nanotheranostics data into an actionable clinical strategy; discuss with industry leaders how nanotheranostics is evolving and what the impact is on current research efforts; and last but not least, learn what approaches are proving fruitful in turning promising clinical data into treatment realities.


Cancer Nanotheranostics: What Have We Learned So Far? Related Books

Cancer Nanotheranostics: What Have We Learned So Far?
Language: en
Pages: 130
Authors: João Conde
Categories: Cancer
Type: BOOK - Published: 2016-03-17 - Publisher: Frontiers Media SA

GET EBOOK

After a quarter of century of rapid technological advances, research has revealed the complexity of cancer, a disease intimately related to the dynamic transfor
Cancer Nanotheranostics
Language: en
Pages: 379
Authors: Muthupandian Saravanan
Categories: Medical
Type: BOOK - Published: 2021-10-05 - Publisher: Springer Nature

GET EBOOK

Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two vo
Handbook of Nanomaterials for Cancer Theranostics
Language: en
Pages: 608
Authors: Joao Conde
Categories: Science
Type: BOOK - Published: 2018-06-27 - Publisher: Elsevier

GET EBOOK

Handbook of Nanomaterials for Cancer Theranostics focuses on recent developments in advanced theranostic nanomedicines from a chemical and biological perspectiv
Nanotheranostics For Personalized Medicine
Language: en
Pages: 346
Authors: Patrick Couvreur
Categories: Medical
Type: BOOK - Published: 2016-02-22 - Publisher: World Scientific

GET EBOOK

The application of nanotechnology in the biomedical field, known as nanomedicine, has gained much interest in the recent past as a versatile strategy for select
Applications of Targeted Nano Drugs and Delivery Systems
Language: en
Pages: 684
Authors: Shyam Mohapatra
Categories: Science
Type: BOOK - Published: 2018-10-05 - Publisher: Elsevier

GET EBOOK

Applications of Targeted Nano-Drugs and Delivery Systems: Nanoscience and Nanotechnology in Drug Delivery explores the applications of Nano-drugs and their deli